Harvard Bioscience Current Ratio 2010-2023 | HBIO

Harvard Bioscience current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Harvard Bioscience Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2023-12-31 $0.05B $0.03B 1.85
2023-09-30 $0.05B $0.02B 2.09
2023-06-30 $0.05B $0.02B 2.29
2023-03-31 $0.05B $0.02B 2.26
2022-12-31 $0.05B $0.02B 2.20
2022-09-30 $0.05B $0.02B 2.43
2022-06-30 $0.06B $0.02B 2.42
2022-03-31 $0.06B $0.03B 2.18
2021-12-31 $0.06B $0.03B 2.43
2021-09-30 $0.06B $0.02B 2.37
2021-06-30 $0.05B $0.02B 2.30
2021-03-31 $0.05B $0.02B 2.38
2020-12-31 $0.05B $0.02B 2.46
2020-09-30 $0.04B $0.02B 2.05
2020-06-30 $0.04B $0.02B 1.95
2020-03-31 $0.05B $0.02B 2.05
2019-12-31 $0.05B $0.03B 2.12
2019-09-30 $0.05B $0.02B 2.41
2019-06-30 $0.05B $0.02B 2.52
2019-03-31 $0.05B $0.02B 2.22
2018-12-31 $0.06B $0.03B 2.27
2018-09-30 $0.06B $0.02B 2.83
2018-06-30 $0.05B $0.02B 2.42
2018-03-31 $0.06B $0.02B 2.50
2017-12-31 $0.05B $0.01B 3.39
2017-09-30 $0.05B $0.01B 3.40
2017-06-30 $0.05B $0.01B 3.46
2017-03-31 $0.05B $0.01B 3.21
2016-12-31 $0.05B $0.02B 3.11
2016-09-30 $0.05B $0.01B 3.20
2016-06-30 $0.05B $0.02B 3.15
2016-03-31 $0.05B $0.02B 3.07
2015-12-31 $0.05B $0.02B 2.62
2015-09-30 $0.05B $0.02B 3.03
2015-06-30 $0.06B $0.02B 2.66
2015-03-31 $0.05B $0.02B 2.67
2014-12-31 $0.06B $0.02B 3.15
2014-09-30 $0.07B $0.02B 4.16
2014-06-30 $0.06B $0.02B 3.94
2014-03-31 $0.06B $0.02B 3.96
2013-12-31 $0.06B $0.02B 3.78
2013-09-30 $0.07B $0.01B 5.48
2013-06-30 $0.07B $0.01B 5.47
2013-03-31 $0.06B $0.01B 4.72
2012-12-31 $0.06B $0.01B 5.96
2012-09-30 $0.06B $0.01B 6.17
2012-06-30 $0.06B $0.01B 5.88
2012-03-31 $0.06B $0.01B 5.45
2011-12-31 $0.06B $0.01B 6.02
2011-09-30 $0.06B $0.01B 5.72
2011-06-30 $0.06B $0.01B 6.08
2011-03-31 $0.06B $0.01B 5.58
2010-12-31 $0.06B $0.01B 5.19
2010-09-30 $0.05B $0.01B 5.42
2010-06-30 $0.05B $0.01B 4.63
2010-03-31 $0.05B $0.01B 4.03
2009-12-31 $0.05B $0.01B 3.93
2009-09-30 $0.05B $0.02B 2.12
2009-06-30 $0.04B $0.01B 4.80
2009-03-31 $0.04B $0.01B 4.28
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.157B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.480B 32.51
Bruker (BRKR) United States $11.768B 31.38
Kewaunee Scientific (KEQU) United States $0.099B 11.71